Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis.
Reinwald
M
M
Uharek
L
L
Lampe
D
D
Grobosch
T
T
Thiel
E
E
Schwartz
S
S
D000208:Acute Disease; D000935:Antifungal Agents / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics; D001228:Aspergillosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy*; D020314:Central Nervous System Fungal Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy; D008172:Lung Diseases, Fungal / Q000134:cerebrospinal fluid* / Q000188:drug therapy*; D008297:Male; D014230:Triazoles / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics; D055815:Young Adult
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole